Market Research Logo

Liver Transplantation - Pipeline Review, H2 2015

Liver Transplantation - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Liver Transplantation - Pipeline Review, H2 2015’, provides an overview of the Liver Transplantation’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Liver Transplantation, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Transplantation and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Liver Transplantation
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Liver Transplantation and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Liver Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Liver Transplantation pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Liver Transplantation
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Liver Transplantation pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Liver Transplantation Overview
Therapeutics Development
Pipeline Products for Liver Transplantation - Overview
Pipeline Products for Liver Transplantation - Comparative Analysis
Liver Transplantation - Therapeutics under Development by Companies
Liver Transplantation - Therapeutics under Investigation by Universities/Institutes
Liver Transplantation - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Liver Transplantation - Products under Development by Companies
Liver Transplantation - Products under Investigation by Universities/Institutes
Liver Transplantation - Companies Involved in Therapeutics Development
Astellas Pharma Inc.
Conatus Pharmaceuticals Inc.
Digna Biotech, S.L.
Dompe Farmaceutici S.p.A.
RedHill Biopharma Ltd.
Liver Transplantation - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ABC-294640 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cardiotrophin-1 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cell Therapy for Liver Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cell Therapy for Liver Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
emricasan - Drug Profile
Product Description
Mechanism of Action
R&D Progress
FX-06 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for High-Grade Glioma and Liver Transplantation - Drug Profile
Product Description
Mechanism of Action
R&D Progress
reparixin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tacrolimus ER - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TR-002 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Liver Transplantation - Recent Pipeline Updates
Liver Transplantation - Dormant Projects
Liver Transplantation - Discontinued Products
Liver Transplantation - Product Development Milestones
Featured News & Press Releases
Nov 16, 2015: Conatus Pharmaceuticals Announces Poster Presentations at AASLD Annual Meeting
May 12, 2014: Conatus Pharmaceuticals Initiates Phase 2b Trial Targeting Fibrosis in Liver Transplant Recipients
Nov 02, 2013: Conatus Pharmaceuticals Presents Data Demonstrating Emricasan's Safety Profile at the AASLD Liver Meeting
Dec 04, 2012: Astellas Pharma Announces Acceptance Of US New Drug Application For Tacrolimus Extended Release Capsules
Oct 20, 2011: European Medicines Agency Agrees To Precautionary Recall Of Advagraf 0.5mg Capsule Batches
Jul 01, 2011: Astellas Introduces Advagraf In India
Mar 16, 2011: Digna Biotech And Biotecnol Receive Spanish Approval For Phase I Clinical Studies Of Cardiotrophin I
Feb 18, 2011: Astellas Introduces Advagraf in China-once daily administration, leading the new trend in immunosuppressive therapy after organ transplant
Oct 02, 2007: New Once-Daily Advagraf Launched Across Europe.
Jun 18, 2007: Advagraf Now Available in Germany and the UK as a Once-Daily Immunosuppressant in Organ Transplantation
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Liver Transplantation, H2 2015
Number of Products under Development for Liver Transplantation - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Liver Transplantation - Pipeline by Astellas Pharma Inc., H2 2015
Liver Transplantation - Pipeline by Conatus Pharmaceuticals Inc., H2 2015
Liver Transplantation - Pipeline by Digna Biotech, S.L., H2 2015
Liver Transplantation - Pipeline by Dompe Farmaceutici S.p.A., H2 2015
Liver Transplantation - Pipeline by RedHill Biopharma Ltd., H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Liver Transplantation Therapeutics - Recent Pipeline Updates, H2 2015
Liver Transplantation - Dormant Projects, H2 2015
Liver Transplantation - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Liver Transplantation, H2 2015
Number of Products under Development for Liver Transplantation - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report